Airways obstruction in survivors of thoracoplasty: reversibility is greater in non-smokers.
OBJECTIVE
Before the advent of antituberculous chemotherapy, thoracoplasty (TPL) was the definitive form of therapy for cavitary pulmonary tuberculosis. This study aimed to characterize the late functional sequelae of TPL, and to establish the degree of reversibility of any consequent airway obstruction.


METHODS
Pulmonary function was studied in 21 long-term (mean 35 years) survivors of TPL between the years 1990-2001.


RESULTS
A mixed obstructive/restrictive defect was found in this patient cohort. After inhalation of bronchodilator, marginal increases in FEV(1) and FVC and marginal decreases in FRC, RV and TLC were observed. Maximum mid-expiratory flow rate was severely reduced (28.8% of predicted), but reversibility after inhaled beta(2)-agonist was highest for this parameter of pulmonary function (mean 11%). Smokers had a higher RV (P = 0.04), suggesting hyperinflation, while non-smokers had a larger increase in FEV(1)/FVC ratio postbronchodilator (P = 0.004), suggesting more marked reversibility of airways obstruction in this group.


CONCLUSIONS
Long-term survivors of TPL have an obstructive as well as a restrictive ventilatory defect. These patients have partial reversibility of the obstructive defect. The degree of reversibility found suggests that bronchodilator therapy may help these patients.
O'Connor
Terence M
TM
Department of Respiratory Medicine, Cork University Hospital, Wilton, Cork, Ireland. oconnotm@mcmaster.ca
O'Riordan
Deirdre M
DM
Stack
Maria
M
Bredin
Charles P
CP
D000368:Aged; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012129:Respiratory Function Tests; D012907:Smoking / Q000503:physiopathology*; D013905:Thoracoplasty; D014397:Tuberculosis, Pulmonary / Q000503:physiopathology* / Q000601:surgery*